Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor—5-HT1A/5-HT2A/5-HT7 and D2/D3/D4—agents: The synthesis and pharmacological evaluation
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2012 |
|---|---|
| Erschienen: |
2012 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Bioorganic & medicinal chemistry - 20(2012), 4 vom: 15. Feb., Seite 1545-1557 |
| Beteiligte Personen: |
Zajdel, Paweł [VerfasserIn] |
|---|
| RVK: |
|---|
| Umfang: |
12 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC188856671X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC188856671X | ||
| 003 | DE-627 | ||
| 005 | 20230713015734.0 | ||
| 007 | tu | ||
| 008 | 120213s2012 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a sw120212_1 |
| 035 | |a (DE-627)OLC188856671X | ||
| 035 | |a (DE-599)GBVOLC188856671X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 540 |a 610 |
| 084 | |a PHARM |2 fid | ||
| 084 | |a VA 2619 |q AVZ |2 rvk | ||
| 100 | 1 | |a Zajdel, Paweł |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor—5-HT1A/5-HT2A/5-HT7 and D2/D3/D4—agents: The synthesis and pharmacological evaluation |
| 264 | 1 | |c 2012 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Marciniec, Krzysztof |4 oth | |
| 700 | 1 | |a Maślankiewicz, Andrzej |4 oth | |
| 700 | 1 | |a Satała, Grzegorz |4 oth | |
| 700 | 1 | |a Duszyńska, Beata |4 oth | |
| 700 | 1 | |a Bojarski, Andrzej J. |4 oth | |
| 700 | 1 | |a Partyka, Anna |4 oth | |
| 700 | 1 | |a Jastrzębska-Więsek, Magdalena |4 oth | |
| 700 | 1 | |a Wróbel, Dagmara |4 oth | |
| 700 | 1 | |a Wesołowska, Anna |4 oth | |
| 700 | 1 | |a Pawłowski, Maciej |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Bioorganic & medicinal chemistry |d Amsterdam [u.a.] : Elsevier, 1993 |g 20(2012), 4 vom: 15. Feb., Seite 1545-1557 |w (DE-627)171175506 |w (DE-600)1161284-8 |w (DE-576)038869047 |x 0968-0896 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2012 |g number:4 |g day:15 |g month:02 |g pages:1545-1557 |g extent:12 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-CHE | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_69 | ||
| 912 | |a GBV_ILN_70 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4305 | ||
| 912 | |a GBV_ILN_4306 | ||
| 936 | r | v | |a VA 2619 |
| 951 | |a AR | ||
| 952 | |d 20 |j 2012 |e 4 |b 15 |c 2 |h 1545-1557 |g 12 | ||